Stocklytics Platform
Asset logo for symbol BIOR
Biora Therapeutics
BIOR52
$0.58arrow_drop_down9.66%-$0.06
Penny Stock
Asset logo for symbol BIOR
BIOR52

$0.58

arrow_drop_down9.66%

Performance History

Chart placeholder
Key Stats
Open$0.64
Prev. Close$0.65
EPS-4.93
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$23.69M
PE Ratio-
LOWHIGH
Day Range0.54
0.64
52 Week Range0.47
2.71
Ratios
Revenue-
EBITDA Margin %-
EPS-4.93

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Biora Therapeutics (BIOR)

BIOR is the stock symbol for Biora Therapeutics, Inc., a biopharmaceutical company that focuses on the development and commercialization of innovative therapeutics for various diseases. BIOR has a history of fluctuating stock prices, which can be attributed to the volatile nature of the biotech industry. Investors should carefully analyze the stock's price history before making any investment decisions.
According to the latest quote, BIOR is currently trading at $X per share. This price reflects the market's perception of the company's potential and future prospects. It is important to note that stock prices can be influenced by various factors such as industry trends, company financials, and market sentiment.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Aditya P. Mohanty M.B.A.
Headquarters
San Diego
Employees
54
Exchange
NASDAQ
add Biora Therapeutics to watchlist

Keep an eye on Biora Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Biora Therapeutics's (BIOR) price per share?

The current price per share for Biora Therapeutics (BIOR) is $0.59. The stock has seen a price change of -$0.06 recently, indicating a -9.66% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Biora Therapeutics (BIOR)?

For Biora Therapeutics (BIOR), the 52-week high is $2.71, which is 362.02% from the current price. The 52-week low is $0.48, the current price is 23.62% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Biora Therapeutics (BIOR) a growth stock?

Biora Therapeutics (BIOR) has shown an average price growth of 0.41% over the past three years. It has received a score of -4 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Biora Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Biora Therapeutics (BIOR) stock price performance year to date (YTD)?

As of the latest data, Biora Therapeutics (BIOR) has a year-to-date price change of -55.85%. Over the past month, the stock has experienced a price change of -16.21%. Over the last three months, the change has been -15.14%. Over the past six months, the figure is -51.47%.
help

Is Biora Therapeutics (BIOR) a profitable company?

Biora Therapeutics (BIOR) has a net income of -$124.33M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -4.96K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$67.14M. Furthermore, the EBITDA is -$67.51M.
help

What is the market capitalization of Biora Therapeutics (BIOR)?

Biora Therapeutics (BIOR) has a market capitalization of $23.7M. The average daily trading volume is 182.05K, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media